Beneficial effects of nasal high flow oxygen therapy after weaning from non­invasive ventilation: A prospective observational study

Takuya Kurazumi, Takeshi Suzuki, Rie Wakamiya, Kikuko Suga, Yoshihisa Morita, Junichi Masuda, Shizuko Kosugi, Nobuyuki Katori, Hiroshi Morisaki

Research output: Contribution to journalArticle

Abstract

It remains unknown whether application of nasal high flow (NHF) is effective after liberation from non-invasive ventilation (NIV). This study was aimed at investigating the effect of NHF in patients ready for weaning from NIV. With institutional ethic committee approval, patients receiving NIV due to hypoxemic respiratory failure for more than 24 hours were enrolled. After passing the weaning criteria with continuous positive airway pressure (CPAP) mode [fraction of inspiratory oxygen (FIO2) ≦0.5, positive end expiratory pressure (PEEP) 4 cmH2O], patients received NHF (Flow 50 L/min, FIO2 ≦0.5) immediately after liberation from NIV. Before the initiation of the study, eight sequential patients who received oxygen via face mask after NIV treatment, served as the historical control. Respiratory parameters [partial pressure of arterial oxygen (PaO2) to FIO2 ratio (P/F ratio), respiratory rate (RR)] 1 hour after liberation from NIV were evaluated with those during NIV as the primary outcome. The frequency of rescue NIV therapy, intubation, and respiratory failure were also recorded. Nine eligible patients received NHF therapy after liberation from NIV. P/F ratio and RR did not change significantly compared with those during NIV (231 ± 43.6 versus 250.7 ± 34.2 mmHg, 20.8 ± 2.3 versus 21 ± 1.6/min), while P/F ratio decreased significantly in the historical control group (194.3 ± 20.1 versus 255.9 ± 58.1 mmHg, p=0.013). Rescue NIV therapy, intubation, and respiratory failure never occurred in the NFH group, although two patients received NIV rescue therapy, of whom one was intubated in the historical control. NHF after liberation from NIV might be effective in patients recovering from hypoxemic respiratory failure. Registration number: UMIN000014133 (UMIN-CTR).

Original languageEnglish
Pages (from-to)157-171
Number of pages15
JournalSigna Vitae
Volume11
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Noninvasive Ventilation
Nose
Observational Studies
Prospective Studies
Oxygen
Respiratory Insufficiency
Therapeutics
Respiratory Rate
Weaning
Intubation
Ethics Committees
Continuous Positive Airway Pressure
Positive-Pressure Respiration
Partial Pressure
Masks

Keywords

  • Hypoxemic respiratory failure
  • Nasal high flow oxygen therapy
  • Non-invasive ventilation
  • Rescue therapy
  • Weaning
  • Weaning failure

ASJC Scopus subject areas

  • Emergency Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Beneficial effects of nasal high flow oxygen therapy after weaning from non­invasive ventilation : A prospective observational study. / Kurazumi, Takuya; Suzuki, Takeshi; Wakamiya, Rie; Suga, Kikuko; Morita, Yoshihisa; Masuda, Junichi; Kosugi, Shizuko; Katori, Nobuyuki; Morisaki, Hiroshi.

In: Signa Vitae, Vol. 11, No. 1, 01.01.2016, p. 157-171.

Research output: Contribution to journalArticle

Kurazumi, Takuya ; Suzuki, Takeshi ; Wakamiya, Rie ; Suga, Kikuko ; Morita, Yoshihisa ; Masuda, Junichi ; Kosugi, Shizuko ; Katori, Nobuyuki ; Morisaki, Hiroshi. / Beneficial effects of nasal high flow oxygen therapy after weaning from non­invasive ventilation : A prospective observational study. In: Signa Vitae. 2016 ; Vol. 11, No. 1. pp. 157-171.
@article{d992d765e06f4595be525f6e6e180eb9,
title = "Beneficial effects of nasal high flow oxygen therapy after weaning from non­invasive ventilation: A prospective observational study",
abstract = "It remains unknown whether application of nasal high flow (NHF) is effective after liberation from non-invasive ventilation (NIV). This study was aimed at investigating the effect of NHF in patients ready for weaning from NIV. With institutional ethic committee approval, patients receiving NIV due to hypoxemic respiratory failure for more than 24 hours were enrolled. After passing the weaning criteria with continuous positive airway pressure (CPAP) mode [fraction of inspiratory oxygen (FIO2) ≦0.5, positive end expiratory pressure (PEEP) 4 cmH2O], patients received NHF (Flow 50 L/min, FIO2 ≦0.5) immediately after liberation from NIV. Before the initiation of the study, eight sequential patients who received oxygen via face mask after NIV treatment, served as the historical control. Respiratory parameters [partial pressure of arterial oxygen (PaO2) to FIO2 ratio (P/F ratio), respiratory rate (RR)] 1 hour after liberation from NIV were evaluated with those during NIV as the primary outcome. The frequency of rescue NIV therapy, intubation, and respiratory failure were also recorded. Nine eligible patients received NHF therapy after liberation from NIV. P/F ratio and RR did not change significantly compared with those during NIV (231 ± 43.6 versus 250.7 ± 34.2 mmHg, 20.8 ± 2.3 versus 21 ± 1.6/min), while P/F ratio decreased significantly in the historical control group (194.3 ± 20.1 versus 255.9 ± 58.1 mmHg, p=0.013). Rescue NIV therapy, intubation, and respiratory failure never occurred in the NFH group, although two patients received NIV rescue therapy, of whom one was intubated in the historical control. NHF after liberation from NIV might be effective in patients recovering from hypoxemic respiratory failure. Registration number: UMIN000014133 (UMIN-CTR).",
keywords = "Hypoxemic respiratory failure, Nasal high flow oxygen therapy, Non-invasive ventilation, Rescue therapy, Weaning, Weaning failure",
author = "Takuya Kurazumi and Takeshi Suzuki and Rie Wakamiya and Kikuko Suga and Yoshihisa Morita and Junichi Masuda and Shizuko Kosugi and Nobuyuki Katori and Hiroshi Morisaki",
year = "2016",
month = "1",
day = "1",
doi = "10.22514/SV111.052016.11",
language = "English",
volume = "11",
pages = "157--171",
journal = "Signa Vitae",
issn = "1334-5605",
publisher = "Pharmamed Mado Ltd.",
number = "1",

}

TY - JOUR

T1 - Beneficial effects of nasal high flow oxygen therapy after weaning from non­invasive ventilation

T2 - A prospective observational study

AU - Kurazumi, Takuya

AU - Suzuki, Takeshi

AU - Wakamiya, Rie

AU - Suga, Kikuko

AU - Morita, Yoshihisa

AU - Masuda, Junichi

AU - Kosugi, Shizuko

AU - Katori, Nobuyuki

AU - Morisaki, Hiroshi

PY - 2016/1/1

Y1 - 2016/1/1

N2 - It remains unknown whether application of nasal high flow (NHF) is effective after liberation from non-invasive ventilation (NIV). This study was aimed at investigating the effect of NHF in patients ready for weaning from NIV. With institutional ethic committee approval, patients receiving NIV due to hypoxemic respiratory failure for more than 24 hours were enrolled. After passing the weaning criteria with continuous positive airway pressure (CPAP) mode [fraction of inspiratory oxygen (FIO2) ≦0.5, positive end expiratory pressure (PEEP) 4 cmH2O], patients received NHF (Flow 50 L/min, FIO2 ≦0.5) immediately after liberation from NIV. Before the initiation of the study, eight sequential patients who received oxygen via face mask after NIV treatment, served as the historical control. Respiratory parameters [partial pressure of arterial oxygen (PaO2) to FIO2 ratio (P/F ratio), respiratory rate (RR)] 1 hour after liberation from NIV were evaluated with those during NIV as the primary outcome. The frequency of rescue NIV therapy, intubation, and respiratory failure were also recorded. Nine eligible patients received NHF therapy after liberation from NIV. P/F ratio and RR did not change significantly compared with those during NIV (231 ± 43.6 versus 250.7 ± 34.2 mmHg, 20.8 ± 2.3 versus 21 ± 1.6/min), while P/F ratio decreased significantly in the historical control group (194.3 ± 20.1 versus 255.9 ± 58.1 mmHg, p=0.013). Rescue NIV therapy, intubation, and respiratory failure never occurred in the NFH group, although two patients received NIV rescue therapy, of whom one was intubated in the historical control. NHF after liberation from NIV might be effective in patients recovering from hypoxemic respiratory failure. Registration number: UMIN000014133 (UMIN-CTR).

AB - It remains unknown whether application of nasal high flow (NHF) is effective after liberation from non-invasive ventilation (NIV). This study was aimed at investigating the effect of NHF in patients ready for weaning from NIV. With institutional ethic committee approval, patients receiving NIV due to hypoxemic respiratory failure for more than 24 hours were enrolled. After passing the weaning criteria with continuous positive airway pressure (CPAP) mode [fraction of inspiratory oxygen (FIO2) ≦0.5, positive end expiratory pressure (PEEP) 4 cmH2O], patients received NHF (Flow 50 L/min, FIO2 ≦0.5) immediately after liberation from NIV. Before the initiation of the study, eight sequential patients who received oxygen via face mask after NIV treatment, served as the historical control. Respiratory parameters [partial pressure of arterial oxygen (PaO2) to FIO2 ratio (P/F ratio), respiratory rate (RR)] 1 hour after liberation from NIV were evaluated with those during NIV as the primary outcome. The frequency of rescue NIV therapy, intubation, and respiratory failure were also recorded. Nine eligible patients received NHF therapy after liberation from NIV. P/F ratio and RR did not change significantly compared with those during NIV (231 ± 43.6 versus 250.7 ± 34.2 mmHg, 20.8 ± 2.3 versus 21 ± 1.6/min), while P/F ratio decreased significantly in the historical control group (194.3 ± 20.1 versus 255.9 ± 58.1 mmHg, p=0.013). Rescue NIV therapy, intubation, and respiratory failure never occurred in the NFH group, although two patients received NIV rescue therapy, of whom one was intubated in the historical control. NHF after liberation from NIV might be effective in patients recovering from hypoxemic respiratory failure. Registration number: UMIN000014133 (UMIN-CTR).

KW - Hypoxemic respiratory failure

KW - Nasal high flow oxygen therapy

KW - Non-invasive ventilation

KW - Rescue therapy

KW - Weaning

KW - Weaning failure

UR - http://www.scopus.com/inward/record.url?scp=85043508576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043508576&partnerID=8YFLogxK

U2 - 10.22514/SV111.052016.11

DO - 10.22514/SV111.052016.11

M3 - Article

AN - SCOPUS:85043508576

VL - 11

SP - 157

EP - 171

JO - Signa Vitae

JF - Signa Vitae

SN - 1334-5605

IS - 1

ER -